Does salmeterol facilitate 'step-down' therapy in patients with asthma receiving moderate to high doses of inhaled corticosteroids?

Current Therapeutic Research - Clinical and Experimental

Volumn 59, Issue 11, 1998, Pages 803-811

  Self, Timothy ^a   Rumbak, Mark J ^b   Kelso, Tiffany ^a,c   Eberle, Louis ^a,d   Abou Shala, Nabil ^a,e   Learned, Cheryl C ^a,f   Beiers, Nicole ^b   Tolley, Elizabeth ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Community Pharmacy Practice ^*  (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^f Medical Center of Plano   (United States)

Author keywords

Asthma; Inhaled corticosteroids; Salmeterol

Indexed keywords

BECLOMETASONE; CORTICOSTEROID; FLUNISOLIDE; PREDNISONE; SALBUTAMOL; SALMETEROL; TRIAMCINOLONE;

ADULT; ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY;

EID: 0031755222     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(98)85106-0     Document Type: Article

References (15)

1. Expert Panel Report. Guidelines for the diagnosis and management of asthma. Bethesda, Md; National Institutes of Health; 1991. Publication No. 91-3642.
2. International Consensus Report on Diagnosis and Management of Asthma. Bethesda, Md; National Institutes of Health; 1992. Publication No. 92-3091.
3. British Thoracic Society. The British guidelines on asthma management. Thorax. 1997;52(Suppl 1):S1-S21.
4. Expert Panel Report II. Guidelines for the diagnosis and management of asthma. Bethesda, Md; National Institutes of Health; 1997. Publication No. 97-4051.
5. Greening AP, Wind P, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet. 1994;344:219-224.
6. Woolcock A, Lundback B, Ringdal N, Jaques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroid. Am J Respir Crit Care Med. 1996;153:1481-1488.
7. Wilding P, Clark M, Coon JT, et al. Effect of long term treatment with salmeterol on asthma control: A double blind, randomised crossover study. BMJ. 1997;314:1441-1446.
8. Juniper EF, Guyatt GH, Epstein RS, et al. Evaluation of impairment of health related quality of life in asthma: Development of a questionnaire for use in clinical trials. Respir Med. 1991;85:76-83.
9. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol. 1994;47:81-87.
10. Milliken GA, Johnson DE. Analyzing split-plot and certain repeated measures experiments with unbalanced and missing data. In: Analysis of Messy Data. Volume I: Designed Experiments. New York: Chapman & Hall; 1992:377-407.
11. Mclvor RA, Pizzichini E, Hussack P, et al. Steroid sparing versus masking effects of salmeterol in asthmatics using high dose inhaled corticosteroid. Am J Respir Crit Care Med. 1997;155:A204. Abstract.
12. Faurschou P, Steffensen I, Jaques L. Effect of addition of inhaled salmeterol to the treatment of moderate to severe asthmatics uncontrolled on high dose inhaled steroids. Eur Respir J. 1996;9:1885-1890.
13. Williams C, Crossland L, Finnerty J, et al. Case-control study of salmeterol and near-fatal attacks of asthma. Thorax. 1998;53:7-13.
14. 2 agonists and the risk of life threatening asthma. Thorax. 1998;53:1-2.
15. Kemp JP, Cook DA, Incaudo GA, et al. Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. J Allergy Clin Immunol. 1998;101:188-195.